Patients taking prescription opioids to manage pain are at a heightened risk of developing opioid use disorder (OUD). This innate risk needs to be vigilantly monitored by health care providers (HCPs) and strategies must be in place to engage patients in treatment when OUD is confirmed. HCPs should be aware of the Diagnostic and Statistical Manual of Mental Disorders’ (DSM-5) criteria for the diagnosis of OUD as well as the risk factors and available risk assessments for OUD. Long-term exposure to opioid therapy causes psychological and neurological changes and practical guidance for safe and thoughtful tapering must be executed slowly to ensure patients’ safety. Additionally, clinicians must be up to date on naloxone prescribing regulations as well as community resources for the psychosocial treatment of OUD.
In this fourth and final installment of a REMS BriefCase series on pain management faculty will discuss the importance of recognizing the signs of OUD and how to intervene if red flags do appear. It is vital that clinicians prescribing opioids monitor their patients closely for OUD and are equipped with the tools needed to safely treat the disorder.
At the end of this CME/CE activity, participants should be able to utilize the DSM-5 criteria to identify and diagnose opioid use disorder (OUD) in patients prescribed opioids for acute and chronic pain. Develop strategies for engaging patients in treatment for OUD.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Physicians, surgeons, dentists, PAs, NPs, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Weimer reports the following financial relationships: Consultant: CVS Health and Path CCM, Inc.
Dr. Potru reports no financial relationships to disclose.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at (877) CME-PROS or (877) 263-7767